Skip to main content
. 2013 Apr 16;76(6):932–938. doi: 10.1111/bcp.12126

Table 1.

Best fit parameters to equation 1 (UT = (1 – D/(ID50 + D)) × (UPUR) + UR) relating the plasma urate concentrations of during treatment (UT) to the plasma concentrations pre-treatment (UP) and the daily dose of allopurinol (D)

Group (n. patients, n. plasma samples) UR (95% CI) mmol l−1 ID50 (95% CI) mg allopurinol daily Statistical parameters (r2, OFV)
All data (46, 112) 0.20 (0.14, 0.25) 226 (170, 303) 0.738, 0.388
All data* (46, 112) 0* 466 (423, 516) 0.680, 0.474
No diuretics (36, 86) 0.14 (0.03, 0.22) 313 (209, 480) 0.670, 0.218
Diuretics (10, 26) 0.24 (0.04, 0.36) 179 (95, 350) 0.739, 0.159
CLcr > 60 ml min−1 (29, 74) 0.20 (0.11, 0.26) 235 (152, 366) 0.609, 0.190
CLcr ≤ 60 ml min−1 (17, 38) 0.17 (0.002, 0.27) 240 (147, 405) 0.782, 0.195
Literature [1822] (125, 184) 0.20 (0.15, 0.23) 186 (140, 241) 0.441, 1.00

CI, confidence interval; CLcr, creatinine clearance; ID50, dose of allopurinol that has reduced the inhibitable urate (UPUR) by 50%; OFV, objective function variable (residual sum of squares); r2, coefficient of determination; UR, apparent resistant plasma concentration of urate.

*

Equation 1 without the resistant urate concentration, i.e. UR is fixed at 0. It is a significantly poorer fit than with the resistant urate concentration (P < 0.001).